McKesson Co. (NYSE:MCK) CEO Brian S. Tyler Sells 8,678 Shares

McKesson Co. (NYSE:MCKGet Rating) CEO Brian S. Tyler sold 8,678 shares of the business’s stock in a transaction dated Tuesday, May 17th. The stock was sold at an average price of $331.43, for a total transaction of $2,876,149.54. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Brian S. Tyler also recently made the following trade(s):

  • On Friday, May 13th, Brian S. Tyler sold 5,438 shares of McKesson stock. The stock was sold at an average price of $322.97, for a total transaction of $1,756,310.86.
  • On Wednesday, May 11th, Brian S. Tyler sold 8,678 shares of McKesson stock. The stock was sold at an average price of $331.45, for a total transaction of $2,876,323.10.
  • On Monday, May 9th, Brian S. Tyler sold 5,438 shares of McKesson stock. The stock was sold at an average price of $330.93, for a total transaction of $1,799,597.34.
  • On Friday, April 29th, Brian S. Tyler sold 5,438 shares of McKesson stock. The stock was sold at an average price of $319.36, for a total transaction of $1,736,679.68.
  • On Monday, April 18th, Brian S. Tyler sold 5,438 shares of McKesson stock. The stock was sold at an average price of $323.25, for a total transaction of $1,757,833.50.

McKesson stock traded down $12.51 during midday trading on Wednesday, reaching $320.65. 979,061 shares of the stock were exchanged, compared to its average volume of 1,198,252. The company’s fifty day moving average is $313.00 and its 200-day moving average is $269.43. The firm has a market cap of $46.61 billion, a PE ratio of 44.56, a PEG ratio of 1.48 and a beta of 0.67. McKesson Co. has a 52 week low of $184.43 and a 52 week high of $339.94.

McKesson (NYSE:MCKGet Rating) last issued its quarterly earnings results on Thursday, May 5th. The company reported $5.83 EPS for the quarter, missing analysts’ consensus estimates of $6.06 by ($0.23). The company had revenue of $66.10 billion during the quarter, compared to the consensus estimate of $63.82 billion. McKesson had a negative return on equity of 538.84% and a net margin of 0.42%. McKesson’s quarterly revenue was up 11.8% on a year-over-year basis. During the same period in the previous year, the company earned $5.05 EPS. As a group, analysts forecast that McKesson Co. will post 23.2 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, July 1st. Stockholders of record on Wednesday, June 1st will be issued a $0.47 dividend. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.59%. The ex-dividend date is Tuesday, May 31st. McKesson’s payout ratio is 26.07%.

Several research analysts recently weighed in on the stock. Credit Suisse Group boosted their price target on shares of McKesson from $333.00 to $377.00 in a report on Wednesday, May 11th. Morgan Stanley boosted their target price on shares of McKesson from $292.00 to $370.00 and gave the company an “overweight” rating in a research note on Tuesday, April 12th. Cowen boosted their target price on shares of McKesson from $325.00 to $361.00 in a research note on Monday, April 18th. TheStreet upgraded shares of McKesson from a “d” rating to a “c+” rating in a research note on Wednesday, February 2nd. Finally, Cowen boosted their target price on shares of McKesson from $325.00 to $361.00 and gave the company an “outperform” rating in a research note on Monday, April 18th. Two research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $320.08.

Several institutional investors have recently made changes to their positions in MCK. Center for Financial Planning Inc. boosted its stake in shares of McKesson by 4.9% in the 3rd quarter. Center for Financial Planning Inc. now owns 4,777 shares of the company’s stock valued at $952,000 after purchasing an additional 222 shares in the last quarter. Rafferty Asset Management LLC boosted its stake in shares of McKesson by 50.6% in the 3rd quarter. Rafferty Asset Management LLC now owns 4,932 shares of the company’s stock valued at $983,000 after purchasing an additional 1,658 shares in the last quarter. Essex Financial Services Inc. boosted its position in McKesson by 36.6% during the 3rd quarter. Essex Financial Services Inc. now owns 2,426 shares of the company’s stock valued at $484,000 after buying an additional 650 shares during the period. CX Institutional boosted its position in McKesson by 2.0% during the 3rd quarter. CX Institutional now owns 10,664 shares of the company’s stock valued at $2,126,000 after buying an additional 208 shares during the period. Finally, BOKF NA purchased a new stake in McKesson during the 3rd quarter valued at $891,000. 85.45% of the stock is owned by institutional investors.

McKesson Company Profile (Get Rating)

McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS).

Featured Articles

Insider Buying and Selling by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.